HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Probucol
Probucol-d6 · dh581 · bisbid · Lorelc · LipoMal · lorelco · PROBUCOL · lurselle

Identifikatoren & physikalische Daten
| CAS No. | 23288-49-5 |
|---|---|
| Summenformel | C31H48O2S2 |
| Durchschnittliche Molmasse | 516,8 g/mol |
| Monoisotopische Masse | 516,30957278 g/mol |
| SMILES | CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 |
| InChIKey | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
| PubChem CID | 4912 |
| ChEMBL | CHEMBL608 |
| ChEBI | CHEBI:8427 |
| EC No. | 245-560-9 |
| DTXSID | DTXSID2045440 |
| Lokaler Name | Probucol |
Chemische & physikalische Eigenschaften
| XLogP | 11,3 |
|---|---|
| Polarare Oberfläche (TPSA) | 91,1 |
| H-Brücken-Donoren | 2 |
| H-Brücken-Akzeptoren | 4 |
| Frei drehbare Bindungen | 8 |
| Schwere Atome | 35 |
| Formalladung | 0 |
| Komplexität | 583 |
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15Pharmaceuticals -> Antilipidemics |
| Löslichkeit | 4.18e-05 g/LChloroform (Slightly), Ethyl Acetate (Slightly) |
| Human Drugs | FDA approved drugs -> Active ingredient |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| Schmelzpunkt | 125 °C126-128°C |
| Physical Description | Solid |
| Collision Cross Section | 216.78 Ų [M+K]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards] |
| Siedepunkt | 571.58°C (rough estimate) |
| Dichte | 1.0008 (rough estimate) |
| Brechungsindex | 1.5341 (estimate) |
| Lagerbedingungen | Keep in dark place,Sealed in dry,Room Temperature |
| Aggregatzustand | Solid |
| pKa (Säurekonstante) | 10.27±0.70(Predicted) |
| Farbe | White to Off-White |
| Merck | 14,7755 |
| Hauptanwendungen | forensics and toxicologypharmaceutical (small molecule) |
| InChI | InChI=1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3 |
| InChIKey | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
| SMILES | C(SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1)(SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1)(C)C |
| CAS Datenbank | 23288-49-5(CAS DataBase Reference) |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Weitere Sicherheitsinformationen | IMAP assessments - Phenol, 4,4'-[(1-methylethylidene)bis(thio)]bis[2,6-bis(1,1-dimethylethyl)-: Environment tier I assessment |
| Hazard Classes and Categories | Skin Irrit. 2 (100%) |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)probucolDILI NegativeOralDOI:10.1016/j.drudis.2019.09.022 |
| Wassergefährdungsklasse (WGK) | 2 |
| Zollcode | 2930902000 |
| RTECS-Nr. | AL3705000 |
| Lagerklasse | 11 - Combustible Solids |
Anwendungen & Verwendung
Verwenden
Probucol is an antilipemic.